DeGette's Loss: Mixed Bag for Drug Industry
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- DeGette lost her seat, and the drug industry loses a key Democratic lawmaker who was knowledgeable about the industry
- DeGette's departure is described as a 'mixed bag' for pharma because, while informed on drug policy, she was 'if not always a friend' of the industry
Why it matters: With DeGette gone, the pharmaceutical industry loses a congressional lawmaker who, despite not always being an industry ally, brought deep knowledge of drug policy to legislative debates. Her departure narrows the pool of Democrats who grasp pharma's technical and regulatory challenges, complicating industry lobbying on Capitol Hill.
Ask SkimNews
